Skip to content

New imaging techniques and normalization investigation of intracranial atherosclerotic stenosis

New imaging techniques and normalization investigation of intracranial atherosclerotic stenosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-14004284
Enrollment
Unknown
Registered
2014-02-21
Start date
2014-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracranial atherosclerotic stenosis

Interventions

Gold Standard:
Index test:

Sponsors

Changhai Hospital affiliated to The Second Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Asymptomatic or symptomatic intracranial middle cerebral artery (MCA) of atherosclerotic stenosis; 2. First imaging examination (CTA and MRA) found that MCA stenosis in proximal M1 or M2 segment, unilateral stenosis rate of 50% or more; Narrow on both sides, one side stenosis rate is 50% or higher, the other side of the narrow rate < 50%; 3. Ultrasound clearly diagnosis there were no or mild carotid stenosis (including intracranial segment of internal carotid artery) (stenosis rate < 30%); 4. Patients aged between 18 to 80 years; 5. Patient has at least one or more than one of the atherosclerosis risk factors: hypertension, diabetes, hyperlipidemia, high homocysteine levels, and smoking history; 6. Patients clearly study purpose and requirements, voluntary study and followed up in accordance with the relevant provisions.

Exclusion criteria

Exclusion criteria: 1. Non atherosclerotic intracranial artery stenosis, Moyamoya disease, arteritis, artery stenosis caused by radiation, acute artery dissection, etc.; 2. Patients with atrial fibrillation, heart valve disease, endocarditis, DCM, left heart mural thrombus or within 6 weeks left ventricular myocardial infarction can fasten a cardiac stroke; 3. Patients who have been known as coagulant function abnormality with relevant symptoms; 4. Patients have been given thrombolysis, intravascular interventional therapy or carotid endarterectomy treatment on acute phase; 5. Imaging quality not up to standard, affect the diagnostic analysis; 6. Patients after MCA stent; 7. Contraindication of MRI or CTA examination, such as: renal failure (eGFR < 30 mL/min / 1.73 m2, try to avoid enhancement examination), contrast allergy, cardiac pacemaker.

Design outcomes

Primary

MeasureTime frame
degree of vascular stenosis;parameters of brain perfusion;plaqu;

Countries

China

Contacts

Public ContactLu Jianping

Changhai Hospital affiliated to The Second Military Medical University

cir.lujianping@vip.163.com+86 13901690556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026